Perspectives on Tuberculosis Pathogenesis and Discovery of Anti-Tubercular Drugs

被引:7
作者
Ntie-Kang, Fidele [1 ,2 ,3 ]
Yong, Joseph N. [4 ]
Owono, Luc C. Owono [1 ,5 ]
Sippl, Wolfgang [3 ]
Megnassan, Eugene [6 ]
机构
[1] Univ Douala, Fac Sci, CEPAMOQ, Douala, Cameroon
[2] Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon
[3] Univ Halle Wittenberg, Dept Pharmaceut Sci, D-06120 Halle, Saale, Germany
[4] Univ Buea, Fac Sci, Dept Chem, Buea, Cameroon
[5] Univ Yaounde I, Ecole Normale Super, Lab Simulat & Biomol Phys, Yaounde, Cameroon
[6] Univ Abobo Adjame, Lab Fundamental & Appl Phys, Abidjan, Cote Ivoire
关键词
Drug discovery; drug resistance; in silico screening; tuberculosis; HIGH-THROUGHPUT DOCKING; MYCOBACTERIUM-TUBERCULOSIS; NATURAL-PRODUCTS; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY; COMBINATORIAL CHEMISTRY; ASPARTIC PROTEASE; POTENT INHIBITORS; THYMIDINE ANALOGS; MEDICINAL-PLANTS;
D O I
10.2174/0929867321666140706144933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on the global burden of tuberculosis and resistant strains that have recently emerged, not responding to existing therapies, it has become urgent to search for new remedies against this global human plague that has been compounded by HIV co-infection. Thus, the search for new drugs against the disease-causing agent, Mycobacterium tuberculosis (MTB), is an ongoing effort. This review discusses the state-of-the-art in anti-tuberculosis pathogenesis and anti-TB drug research, identifying some of the challenges being faced by researchers in the field and sheds light on possible ways forward, particularly in low-income countries.
引用
收藏
页码:3466 / 3477
页数:12
相关论文
共 153 条
[101]   AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants [J].
Ntie-Kang, Fidele ;
Zofou, Denis ;
Babiaka, Smith B. ;
Meudom, Rolande ;
Scharfe, Michael ;
Lifongo, Lydia L. ;
Mbah, James A. ;
Mbaze, Luc Mevaa ;
Sippl, Wolfgang ;
Efange, Simon M. N. .
PLOS ONE, 2013, 8 (10)
[102]   CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening [J].
Ntie-Kang, Fidele ;
Mbah, James A. ;
Mbaze, Luc Meva'a ;
Lifongo, Lydia L. ;
Scharfe, Michael ;
Hanna, Joelle Ngo ;
Cho-Ngwa, Fidelis ;
Onguene, Pascal Amoa ;
Owono, Luc C. Owono ;
Megnassan, Eugene ;
Sippl, Wolfgang ;
Efange, Simon M. N. .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13
[103]  
Ntziora F, 2007, INT J TUBERC LUNG D, V11, P606
[104]   Innovative lead discovery strategies for tropical diseases [J].
Nwaka, Solomon ;
Hudson, Alan .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (11) :941-955
[105]   Developing ANDI: A Novel Approach to Health Product R&D in Africa [J].
Nwaka, Solomon ;
Ilunga, Tshinko B. ;
Da Silva, Jorge Santos ;
Verde, Emiliano Rial ;
Hackley, Doan ;
De Vre, Raymond ;
Mboya-Okeyo, Tom ;
Ridley, Robert G. .
PLOS MEDICINE, 2010, 7 (06)
[106]   Advancing Drug Innovation for Neglected Diseases-Criteria for Lead Progression [J].
Nwaka, Solomon ;
Ramirez, Bernadette ;
Brun, Reto ;
Maes, Louis ;
Douglas, Frank ;
Ridley, Robert .
PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (08)
[107]   Analysis of rpoB and pncA mutations in the published literature:: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? [J].
O'Sullivan, DM ;
McHugh, TD ;
Gillespie, SH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) :674-679
[108]   Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity [J].
Ocampo, MTA ;
Chaung, W ;
Marenstein, DR ;
Chan, MK ;
Altamirano, A ;
Basu, AK ;
Boorstein, RJ ;
Cunningham, RP ;
Teebor, GW .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (17) :6111-6121
[109]   Lead Generation and Optimization Based on Protein-Ligand Complementarity [J].
Ogata, Koji ;
Isomura, Tetsu ;
Kawata, Shinji ;
Yamashita, Hiroshi ;
Kubodera, Hideo ;
Wodak, Shoshana J. .
MOLECULES, 2010, 15 (06) :4382-4400
[110]   Natural antimycobacterial metabolites: current status [J].
Okunade, AL ;
Elvin-Lewis, MPF ;
Lewis, WH .
PHYTOCHEMISTRY, 2004, 65 (08) :1017-1032